Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
85 Patents
#75 in San Diego, CA
#1,014 in California
#4,378 in US
#8,962 in the World
Halozyme, Inc.
Forward Citations = 1,518
63 inventors:
San Diego, CA, United States of America
Halozyme, Inc.
% Expired Patents = 20.0
CIPO Patents = 6
EPO Patents = 24
Trademarks = 6
Forward Citations = 1,518
Loading Chart...
Loading Chart...
63 inventors (with patents filed for the assignee):
Gregory Ian Frost (38 out of 39 patents)
Louis Howard Bookbinder (30 out of 30 patents)
H Michael Shepard (29 out of 60 patents)
4. Robert James Connor (27 out of 28 patents)
5. Ge Wei (24 out of 25 patents)
6. Anirban Kundu (23 out of 23 patents)
7. Qiping Zhao (21 out of 21 patents)
8. Kevin David Swanson (11 out of 31 patents)
9. Baylor Frantz (9 out of 9 patents)
10. Curtis B Thompson (8 out of 8 patents)
11. Scott Beacher (8 out of 8 patents)
12. David W Kang (6 out of 6 patents)
13. Mike Travanty (6 out of 6 patents)
14. Tara Nekoroski (6 out of 6 patents)
15. Xiaoming Li (4 out of 19 patents)
Core Competencies:
Hyaluronidase
PH20 Polypeptide
Injection Device
Tumor Treatment
High Volume Administration
Glycosaminoglycanases
Combination Therapy
Super Fast-Acting Insulin
Soluble Glycoproteins
Adenosine Deaminase
Post-Prandial Glucose Control
Companion Diagnostics
85 patents:
Company Overview
Halozyme, Inc. is a biotechnology company based in San Diego, California, specializing in the development of innovative therapies utilizing hyaluronidase enzymes. The company focuses on enhancing the delivery of biologics and improving patient outcomes through its proprietary PH20 polypeptide technology. Halozyme's research encompasses various applications, including tumor treatment, high-volume administration, and combination therapies, as well as advancements in super fast-acting insulin formulations. Its commitment to transforming therapeutic delivery positions it as a leader in the biopharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Halozyme, Inc.. Retrieved from https://idiyas.com/company/halozyme
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
6 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
24 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]